many) from an antecubital vein of a nondominant arm. The first portion of blood (2 ml) was discarded to minimize the effect of normal saline used as a flushing solution. Subsequently, 4 blood samples were drawn: 12.5 ml at baseline and then 3 samples of 10 ml each. Dilution process was carried out immediately after blood sampling.
Introduction
Fluid resuscitation is essential to maintain or restore normovolemia during massive bleeding. Both crystalloids and colloids, by decreasing concentration of coagulation factors and number of platelets, cause dilutional coagulopathy. Additionally, synthetic colloids specifically impair polymerization of fibrin and platelet function, aggravating hemostatic disturbances. 1 Their administration may therefore increase postoperative blood loss. 2 Hydroxyethyl starch (HES) affects fibrin -based clot firmness more than normal saline and Ringer's lactate solution.
3 The dilutional coagulopathy produced with gelatin induces fewer coagulation abnormalities than HES. 4 Moreover, there is a growing body of evidence that the carrier of the particles may influence hemostasis to some extent, and balanced solutions of crystalloids and colloids are considered safer than saline. 5 We aimed to compare the in vitro effects of balanced crystalloid and 2 balanced colloids on coagulation and fibrinolysis, using rotational thromboelastometry (ROTEM). Sampling Venous blood samples were drawn through a 16 -G or 18 -G indwelling cannula
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Hooves better than potatoes: in vitro effects of balanced crystalloid and colloids on functional parameters of coagulation and fibrinolysis Discussion Our ex vivo study showed a minor effect of the balanced crystalloid at hemodilution of 20%. Dilution with gelatin impaired coagulation to a lesser extent than HES. The most pronounced effect of HES was the decrease in fibrinogen levels and impaired fibrin polymerization. Fibrinolysis was undisturbed by all balanced solutions.
We decided to implement the ROTEM analysis as the most reliable method of hemostasis assessment. Three assays were used: INTEM, EXTEM, and FIBTEM. INTEM is dependent on coagulation factors (XII, XI, IX, VIII, X, V, II, I), platelets, and fibrinolysis. Contributors to EXTEM are coagulation factors (VII, X, V, II, I), platelets, and fibrinolysis. Finally, FIBTEM is carried out to perform differential diagnosis between fibrinogen depletion, fibrinogen dysfunction, and platelet dysfunction. Fibrinogen is an essential precursor of CF.
In our in vitro study, dilution with balanced medium -molecular -weight HES with low degree of substitution (ie, 0.4) impaired hemostasis to a higher extent than balanced gelatin. This effect was demonstrated by deranged parameters obtained with 3 ROTEM assays. Using INTEM, we showed decreased CF (CFT, AA) and clot firmness (amplitude at different time points, MCF) induced by Volulyte® and Geloplasma®, although the effect for Volulyte® was more pronounced. In the FIBTEM assay, CF and clot strength was impaired exclusively by Volulyte®.
The clinical coagulopathic effects are mostly seen when large volume (>1.5 l) of colloids have been infused or in patients with previous coagulopathy. 6 In our study, we used moderate dosing of HES. The real novelty of our findings is that, although we used the dose of HES that is recommended by the manufacturer, we still showed negative impact of this solution on hemostasis. Our findings therefore support the recommendation against the use of HES in this context.
According to previous studies, dilution with gelatin reduces CF to a lesser degree than HES. 7 Several in vitro and in vivo studies have demonstrated that gelatin solution has only moderate effects on the hemostatic process as compared to other colloids. It is noteworthy that the effects of gelatin on coagulation are almost completely reversed by increasing the concentration of fibrinogen. 4 Our , and area under the clotting curve at different time points (minutes) (AR5, AR10, AR15, AR20, AR25; no reference values established). MCF is the maximum firmness of the clot and is influenced by fibrin, platelets, and factor XIII.
Statistical analysis
The statistical analysis was performed using the MedCalc statistical software (Version 16.1 2016, MedCalc Software bvba, Belgium). Demographic characteristics were shown as a mean (SD). All ROTEM values were presented as a median and interquartile range. The differences between undiluted and diluted samples were assessed using tests for repeated measures (repeated analysis of variance or Friedman test). The level of statistical significance was set at a P value of less than 0.05.
Results
The baseline results of standard laboratory tests of coagulation are provided in TABLE 1. The effects of all investigated fluids on coagulation are presented in Supplementary material online, Table S1 . Plasmalyte® had no impact on ex vivo hemostasis. Significant dilution was observed only for colloids, and Geloplasma® produced fewer coagulation abnormalities than HES. In INTEM, we found impaired CF (measured by CFT and AA) as well as clot strength (measured by A10, A15, A20, and MCF). FIBTEM and EXTEM CT fell outside the reference values only for HES. Other parameters reflecting fibrinogen contribution to clot strength were also impaired only by HES. No test solution impacted EXTEM parameters of clot firmness (ie, A10, A15, A20, and MCF). No effect on fibrinolysis (as evidenced by ML) in INTEM and EXTEM was noticed for all solutions. 
